Could Rigorous Diagnosis and Management of Hypertension Reduce Cardiac Events in Patients With Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors? — Aristotle Bamias (2009) | RDL Network
Could Rigorous Diagnosis and Management of Hypertension Reduce Cardiac Events in Patients With Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors?
Letter 2009 en
Authors
AB
Aristotle Bamias
GL
G. Lainakis
EM
Efstathios Manios
Abstract
1 min read
we agree that for specific subsets of postmenopausal patients, tamoxifen will still represent the adjuvant endocrine therapy of choice.However, while waiting for the promises of personalized medicine to become reality, we shall not agree that "up-front aromatase inhibitors can be recommended only in women who have contraindications to the use of tamoxifen."
Chloe Pek Sang Tang, Professor Gregory Lip, Terry McCormack, Alexander R. Lyon, Peter Hillmen, Sunil Iyengar, Nicolás Martínez‐Calle, Nilima Parry‐Jones, Piers Patten, Anna Schuh, Renata Walewska
Discussion(0)
No comments yet. Be the first to comment.